The role of SPARC in lung fibrosis

SPARC在肺纤维化中的作用

基本信息

  • 批准号:
    8432592
  • 负责人:
  • 金额:
    $ 42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-21 至 2018-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): National attention has been drawn to asbestos-related diseases (ARD) due to the serious health situation in Libby, Montana. For almost 60 years Libby miners and residents were exposed to asbestos- contaminated vermiculite from a mining operation near town. Both occupationally- and environmentally- exposed individuals have shown a much higher incidence of ARD than the rest of the population (ATSDR, 2003). However, exposure to the asbestos-contaminated vermiculite is not limited to Libby residents: distribution of this vermiculite nationwide and the long latent period for disease development make asbestos-related diseases (ARD) a continuing public health issue. We previously investigated gene expression changes in a mouse model of asbestos exposure and identified a candidate gene for study that we hypothesize plays a role in disease progression. SPARC (secreted protein acidic and rich in cysteine) demonstrates reproducibly increased expression in mouse lungs exposed to several types of asbestos fibers, including the Libby amphibole. SPARC is a matricellular protein involved in the regulation of extracellular matrix (ECM) - cell interactions through a hypothesized modulation of growth factor activity. The goal of this project is to delineate the role of SPARC in response to exposure to the Libby amphibole and crocidolite asbestos as a positive control. The hypothesis to be tested in our studies is that expression of SPARC is a significant step in the development of lung fibrosis after asbestos exposure. To test the hypothesis, the specific aims will 1) ssess the in vivo expression of SPARC and proteins in the TGF-¿ signaling cascade in SPARC-null and matched wild-type mice after induction of lung fibrosis through intratracheal asbestos instillation, and compare this with the effects of subsequent RNAi transduction to control SPARC expression in wild-type mice, and 2) establish the in vitro gene and protein expression of SPARC as well as extracellular matrix production in mouse primary lung fibroblasts and an immortalized human lung fibroblast cell line stimulated by TGF-¿ or amphiboles before and after Sparc expression inhibition by RNAi. The investigation proposed here will further determine the role of SPARC in fibrosis development after amphibole exposure, specifically targeting how inhibition of SPARC expression can regulate ECM production. Proteins involved in pathways regulated by SPARC could provide targets for potential therapies that might also be beneficial for the treatment of similar, non-asbestos caused diseases such as idiopathic pulmonary fibrosis.
描述(由申请人提供):由于蒙大拿州利比的严重健康状况,石棉相关疾病(ARD)已引起全国关注。在近60年的时间里,利比矿工和居民接触到了镇上附近采矿作业产生的石棉污染的蛭石。职业和环境暴露的个人都表现出比其他人口更高的ARD发病率(ATSDR,2003)。然而,接触石棉污染的蛭石并不局限于利比居民:这种蛭石在全国范围内的分布以及疾病发展的长期潜伏期使石棉相关疾病(ARD)成为一个持续的公共卫生问题。我们之前研究了暴露于石棉的小鼠模型中基因表达的变化,并确定了一个候选基因,我们假设该基因在疾病进展中起作用。SPARC(酸性和富含半胱氨酸的分泌蛋白)显示,暴露于几种类型的石棉纤维(包括Libby闪石)的小鼠肺中的表达可重复增加。SPARC是一种基质细胞蛋白,通过对生长因子活性的假想调节来调节细胞外基质(ECM)-细胞间的相互作用。该项目的目标是描述SPARC在应对暴露于Libby闪石和青石棉作为阳性对照方面的作用。我们的研究中要检验的假设是,SPARC的表达是石棉暴露后肺纤维化发展过程中的重要一步。为了验证这一假说,特定的目标将1)在气管内注入石棉诱导肺纤维化后,在SPARC基因缺失和匹配的野生型小鼠中检测SPARC和转化生长因子-β信号级联中的蛋白的活体表达,并进行比较 2)建立体外培养的小鼠肺成纤维细胞和永生化人肺成纤维细胞系中SPARC基因和蛋白的表达以及细胞外基质的产生情况;2)在RNAi抑制SPARC表达前后,用转化生长因子β或角闪剂刺激永生化人肺成纤维细胞系。本文提出的研究将进一步确定SPARC在闪石暴露后纤维化发展中的作用,特别是针对抑制SPARC表达如何调节细胞外基质的产生。参与SPARC调控的通路的蛋白质可以为潜在的治疗提供靶点,这些治疗可能也有利于治疗类似的非石棉引起的疾病,如特发性肺纤维化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elizabeth A Putnam其他文献

Elizabeth A Putnam的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elizabeth A Putnam', 18)}}的其他基金

RESPONSE IN LUNG EXTRACELLULAR MATRIX TO ASBESTOS
肺细胞外基质对石棉的反应
  • 批准号:
    7959561
  • 财政年份:
    2009
  • 资助金额:
    $ 42万
  • 项目类别:
RESPONSE IN LUNG EXTRACELLULAR MATRIX TO ASBESTOS
肺细胞外基质对石棉的反应
  • 批准号:
    7720584
  • 财政年份:
    2008
  • 资助金额:
    $ 42万
  • 项目类别:
RESPONSE IN LUNG EXTRACELLULAR MATRIX TO ASBESTOS
肺细胞外基质对石棉的反应
  • 批准号:
    7610424
  • 财政年份:
    2007
  • 资助金额:
    $ 42万
  • 项目类别:
RESPONSE IN LUNG EXTRACELLULAR MATRIX TO ASBESTOS
肺细胞外基质对石棉的反应
  • 批准号:
    7385766
  • 财政年份:
    2006
  • 资助金额:
    $ 42万
  • 项目类别:
"Directions and Needs in Asbestos Research - New Insights"
“石棉研究的方向和需求 - 新见解”
  • 批准号:
    7001779
  • 财政年份:
    2005
  • 资助金额:
    $ 42万
  • 项目类别:
Investigations of Asbestos-Related Diseases
石棉相关疾病的调查
  • 批准号:
    6625827
  • 财政年份:
    2002
  • 资助金额:
    $ 42万
  • 项目类别:
Investigations of Asbestos-Related Diseases
石棉相关疾病的调查
  • 批准号:
    6479351
  • 财政年份:
    2002
  • 资助金额:
    $ 42万
  • 项目类别:
Investigations of Asbestos-Related Diseases
石棉相关疾病的调查
  • 批准号:
    6744137
  • 财政年份:
    2002
  • 资助金额:
    $ 42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了